Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Potassium channel protein subunit Kir6.2 is a pore-forming component of ATP-sensitive potassium (KATP) channels, primarily encoded by the gene KCNJ11. These channels are hetero-octameric complexes composed of four central Kir6.2 subunits surrounded by four regulatory sulfonylurea receptor 1 (SUR1) units; together they play a crucial role in linking cellular metabolism with electrical excitability across various tissues, most notably pancreatic β-cells where they regulate insulin secretion in response to blood glucose levels. Mutations in Kir6.2 can lead either to congenital hyperinsulinism or permanent neonatal diabetes mellitus depending on whether they increase or decrease sensitivity to ATP inhibition respectively; some mutations are also associated with neurological symptoms when affecting neuronal isoforms. Drugs such as glibenclamide act as pharmacochaperones or inhibitors by binding within SUR1 but stabilizing interactions critical for proper assembly and function involving both SUR and Kir components—ultimately modulating ion flow through this essential metabolic sensor complex.
Channel inhibition by sulfonylureas and related drugs, which bind the regulatory SUR subunit but affect the function of the Kir6.2 pore-forming unit, leading to closure of the KATP channels and stimulation of insulin secretion from pancreatic β-cells.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Potassium channel protein subunit Kir6.2 (Kir6.2).